These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 30889905)
61. Pancreatitis among patients with cystic fibrosis: correlation with pancreatic status and genotype. De Boeck K; Weren M; Proesmans M; Kerem E Pediatrics; 2005 Apr; 115(4):e463-9. PubMed ID: 15772171 [TBL] [Abstract][Full Text] [Related]
62. Cysteine supplementation and reduction of total parenteral nutrition-induced hepatic lipid accumulation in the weanling rat. Narkewicz MR; Caldwell S; Jones G J Pediatr Gastroenterol Nutr; 1995 Jul; 21(1):18-24. PubMed ID: 8576809 [TBL] [Abstract][Full Text] [Related]
63. [Concentration of plasma beta-carotene in cystic fibrosis children with pancreatic insufficiency]. Laskowska-Klita T; Chełchowska M Med Wieku Rozwoj; 2002; 6(3):267-72. PubMed ID: 12637781 [TBL] [Abstract][Full Text] [Related]
64. Differential metabolism of choline supplements in adult volunteers. Böckmann KA; Franz AR; Minarski M; Shunova A; Maiwald CA; Schwarz J; Gross M; Poets CF; Bernhard W Eur J Nutr; 2022 Feb; 61(1):219-230. PubMed ID: 34287673 [TBL] [Abstract][Full Text] [Related]
66. Reversal of hepatic steatosis by omega-3 fatty acids measured non-invasively by (1) H-magnetic resonance spectroscopy in a rat model. Marsman HA; Heger M; Kloek JJ; Nienhuis SL; van Werven JR; Nederveen AJ; Ten Kate FJ; Stoker J; van Gulik TM J Gastroenterol Hepatol; 2011 Feb; 26(2):356-63. PubMed ID: 21261727 [TBL] [Abstract][Full Text] [Related]
67. Choline deficiency causes reversible hepatic abnormalities in patients receiving parenteral nutrition: proof of a human choline requirement: a placebo-controlled trial. Buchman AL; Ament ME; Sohel M; Dubin M; Jenden DJ; Roch M; Pownall H; Farley W; Awal M; Ahn C JPEN J Parenter Enteral Nutr; 2001; 25(5):260-8. PubMed ID: 11531217 [TBL] [Abstract][Full Text] [Related]
68. Investigating the effects of long-term dornase alfa use on lung function using registry data. Newsome SJ; Daniel RM; Carr SB; Bilton D; Keogh RH J Cyst Fibros; 2019 Jan; 18(1):110-117. PubMed ID: 30172681 [TBL] [Abstract][Full Text] [Related]
69. Dietary supplementation with pressurized whey in patients with cystic fibrosis. Lands LC; Iskandar M; Beaudoin N; Meehan B; Dauletbaev N; Berthiuame Y J Med Food; 2010 Feb; 13(1):77-82. PubMed ID: 20136439 [TBL] [Abstract][Full Text] [Related]
70. Increased rate of lung function decline in Australian adolescents with cystic fibrosis. Welsh L; Robertson CF; Ranganathan SC Pediatr Pulmonol; 2014 Sep; 49(9):873-7. PubMed ID: 24178906 [TBL] [Abstract][Full Text] [Related]
71. Lecithin increases plasma free choline and decreases hepatic steatosis in long-term total parenteral nutrition patients. Buchman AL; Dubin M; Jenden D; Moukarzel A; Roch MH; Rice K; Gornbein J; Ament ME; Eckhert CD Gastroenterology; 1992 Apr; 102(4 Pt 1):1363-70. PubMed ID: 1551541 [TBL] [Abstract][Full Text] [Related]
72. Lung function changes before and after pulmonary exacerbation antimicrobial treatment in cystic fibrosis. Wagener JS; VanDevanter DR; Konstan MW; Pasta DJ; Millar SJ; Morgan WJ Pediatr Pulmonol; 2020 Mar; 55(3):828-834. PubMed ID: 31746561 [TBL] [Abstract][Full Text] [Related]
74. Increased whole body hydroxyproline production as assessed by a new stable isotope technique is associated with hip and spine bone mineral loss in cystic fibrosis. Engelen MP; Com G; Deutz NE Clin Nutr; 2014 Dec; 33(6):1117-21. PubMed ID: 24423745 [TBL] [Abstract][Full Text] [Related]
75. Potentiators (specific therapies for class III and IV mutations) for cystic fibrosis. Patel S; Sinha IP; Dwan K; Echevarria C; Schechter M; Southern KW Cochrane Database Syst Rev; 2015 Mar; (3):CD009841. PubMed ID: 25811419 [TBL] [Abstract][Full Text] [Related]
76. The effect of zinc supplements in cystic fibrosis patients. Van Biervliet S; Vande Velde S; Van Biervliet JP; Robberecht E Ann Nutr Metab; 2008; 52(2):152-6. PubMed ID: 18446019 [TBL] [Abstract][Full Text] [Related]
77. A pre-post retrospective study of patients with cystic fibrosis and gastrostomy tubes. Best C; Brearley A; Gaillard P; Regelmann W; Billings J; Dunitz J; Phillips J; Holme B; Schwarzenberg SJ J Pediatr Gastroenterol Nutr; 2011 Oct; 53(4):453-8. PubMed ID: 21613963 [TBL] [Abstract][Full Text] [Related]
78. Choline deficiency: a cause of hepatic steatosis during parenteral nutrition that can be reversed with intravenous choline supplementation. Buchman AL; Dubin MD; Moukarzel AA; Jenden DJ; Roch M; Rice KM; Gornbein J; Ament ME Hepatology; 1995 Nov; 22(5):1399-403. PubMed ID: 7590654 [TBL] [Abstract][Full Text] [Related]
79. Plasma metabolomics in adults with cystic fibrosis during a pulmonary exacerbation: A pilot randomized study of high-dose vitamin D Alvarez JA; Chong EY; Walker DI; Chandler JD; Michalski ES; Grossmann RE; Uppal K; Li S; Frediani JK; Tirouvanziam R; Tran VT; Tangpricha V; Jones DP; Ziegler TR Metabolism; 2017 May; 70():31-41. PubMed ID: 28403943 [TBL] [Abstract][Full Text] [Related]
80. Verbal and visual memory improve after choline supplementation in long-term total parenteral nutrition: a pilot study. Buchman AL; Sohel M; Brown M; Jenden DJ; Ahn C; Roch M; Brawley TL JPEN J Parenter Enteral Nutr; 2001; 25(1):30-5. PubMed ID: 11190987 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]